<DOC>
	<DOC>NCT01637662</DOC>
	<brief_summary>To investigate headache score and accompanying symptoms during and after infusion of the natriuretic peptides.</brief_summary>
	<brief_title>Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<criteria>Healthy volunteers Aged 1840 50100 kg Fertile women must use safe contraceptives (IUD, oral contraceptives, surgical sterilisation and long lasting gestagen. Tension type headache more than once/month Other primary headaches Daily medication except contraceptives Drug taken within 4 times the halflife for the specific drug except contraceptives Pregnant or lactating women Exposure to radiation within the last year Headache within the last 24 hours before start of trial Hypertension Hypotension Respiratory or cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>